Piramal Pharma completes acquisition of Hemmo Pharmaceuticals

In March this year, Piramal Pharma Ltd entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals for an upfront consideration of Rs 775 crore and earn-outs linked to the achievement of milestones.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3d61jtI
via IFTTT